Errik Anderson

Errik Anderson has extensive work experience in the biotech and healthcare industry. Errik is the CEO, Chairman, and Founder of Alloy Therapeutics, Inc. since 2017. In 2020, they became the President of New Frontier Biologics. Errik is also the Co-Founder and Owner of New England Free Jacks since 2018. In 2013, they founded Ulysses Diversified Holdings, a private diversified holding company. Errik is a Board Member of WelbeHealth since 2018. Errik co-founded Adimab, LLC in 2007, where they served as the Chief Operating Officer and VP of Operations until 2014. In 2013, Errik co-founded Compass Therapeutics LLC and served as the Chief Operating Officer until 2017. Errik is also a co-founder of Alector, Arsanis, and Avitide, Inc., holding various positions in each company. Overall, Errik Anderson has played key roles in founding and leading multiple biotech companies in the industry.

Errik Anderson's education history begins in 1996 when they attended Dartmouth College, where they obtained their A.B. degree in Economics in 2000. Errik then pursued further education at the Thayer School of Engineering at Dartmouth from 2003 to 2007, where they started but did not complete their M.S. degree in Biomolecular Engineering. During the same period, from 2003 to 2007, they also attended The Tuck School of Business at Dartmouth, earning their MBA degree.